Literature DB >> 7577635

Splenic irradiation for chronic autoimmune thrombocytopenic purpura in patients with contra-indications to splenectomy.

M T Caulier1, F Darloy, C Rose, G Camier, P Morel, F Bauters, P Fenaux.   

Abstract

We treated by splenic irradiation eight patients with chronic idiopathic thrombocytopenic purpura (ITP, seven cases) or secondary autoimmune thrombocytopenic purpura (one case) who had contra-indications to splenectomy. A total dose of 15 Gy was delivered to the spleen, with left kidney protection. One patient had a good durable response (> 1 year); two patients had a good transient response (of 3 months duration) but they responded again to a second course of irradiation; two patients had only partial response, but have required no other treatments for 2 years; the three remaining patients had no response. Side-effects were minor. Therefore splenic irradiation appears to be a therapeutic option in patients with chronic ITP who have contra-indications to splenectomy.

Entities:  

Mesh:

Year:  1995        PMID: 7577635     DOI: 10.1111/j.1365-2141.1995.tb05271.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  3 in total

Review 1.  [Chronic idiopathic thrombocytopenic purpura. Current therapy concept and introduction to pathophysiologic, clinical and diagnostic aspects].

Authors:  A Böcher; F G Hagmann; H Kreiter
Journal:  Med Klin (Munich)       Date:  1998-12-15

2.  Primary histiocytic sarcoma of the spleen associated with hemophagocytosis.

Authors:  Koji Oka; Hirokazu Nakamine; Kunihiko Maeda; Mitsunori Yamakawa; Hiroshi Imai; Kohei Tada; Motohiro Ito; Yasuyuki Watanabe; Hikoji Suzuki; Makoto Iwasa; Isao Tanaka
Journal:  Int J Hematol       Date:  2008-05       Impact factor: 2.490

Review 3.  The thrombocytopenic purpuras. Recognition and management.

Authors:  S Gillis
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.